Brad Rubin is currently the Global Forecasting Lead at Biogen, supporting the company's lupus franchise. Previously, they held various senior roles in commercial strategy and analytics at Vericel Corporation from 2016 to 2018, and worked as a consultant at ClearView Healthcare Partners and Simon-Kucher & Partners from 2014 to 2014 and 2012 to 2014, respectively. Brad's academic background includes a PhD in Cell Biology from Yale University, where their research focused on insulin-responsive GLUT4 trafficking. They also earned a B.S. in Biology from the Massachusetts Institute of Technology in 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices